{"id":"W2135936995","doi":"10.1016/s2352-3026(14)70018-3","title":"Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials","year":2014,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":284,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; London Health Sciences Centre","funders":"Bayer HealthCare","keywords":"Medicine; Rivaroxaban; Vitamin K antagonist; Pulmonary embolism; Regimen; Population; Internal medicine; Venous thrombosis; Randomized controlled trial; Warfarin; Cancer; Low molecular weight heparin; Surgery; Thrombosis; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004253064,0.003503166,0.01480367,0.001595701,0.0005475644,0.00248125,0.001383981,0.002773286,0.004849978],"category_scores_gemma":[0.008822444,0.001480493,0.01924634,0.001377174,0.001003457,0.001626099,0.001112354,0.003514805,0.0005073971],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001598876,"about_ca_system_score_gemma":0.001239596,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003539724,"about_ca_topic_score_gemma":0.006763182,"domain_scores_codex":[0.9961855,0.001850794,0.0008464519,0.0005356132,0.0002843296,0.0002973172],"domain_scores_gemma":[0.9969987,0.001653465,0.0007915688,0.0002073032,0.0001634197,0.0001856389],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.7770845,0.0002406284,0.001259344,0.02761409,0.1791529,0.0001066434,0.0001076685,0.0006437603,0.001129409,0.000141783,0.0006297286,0.01188956],"study_design_scores_gemma":[0.7725913,0.007714073,0.004141121,0.00144874,0.211141,0.000104874,0.0001088249,0.0006185396,0.0004304937,0.0005196297,0.00110405,0.00007740905],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5416268,0.4325033,0.004795525,0.001558528,0.004511288,0.006595568,0.00448254,0.000404571,0.003521838],"genre_scores_gemma":[0.9191869,0.06625088,0.002962793,0.001674627,0.001246075,0.004150518,0.00162684,0.00007765911,0.002823627],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01480367,"threshold_uncertainty_score":0.02249259,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02850244584894512,"score_gpt":0.3141589095006511,"score_spread":0.2856564636517059,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}